TrialThe New England journal of medicine2010
Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis.
Srdan Verstovsek et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
598 papers cite itlatest 60 shown
this paperpooled ittrialcites it